Clinical Trials Logo

Groin Injury clinical trials

View clinical trials related to Groin Injury.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06104722 Recruiting - Groin Injury Clinical Trials

Comparison of the Effect of Copenhagen Adduction Exercises Performed at Different Load-intensity

Start date: January 15, 2024
Phase: N/A
Study type: Interventional

The aim of our study is to compare the effects of the Copenhagen adduction exercise, performed at different loading intensities, on hip muscle strength development, performance, flexibility, and delayed onset muscle soreness. The study will include active taekwondo athletes between the ages of 12-18. Athletes will be randomly divided into two groups: a low-intensity Copenhagen Adduction exercise group and a high-intensity Copenhagen Adduction exercise group. Athletes in both the low-intensity and high-intensity exercise groups will perform the exercise for 8 weeks in addition to their regular training program. At the beginning of the study and at the 4th, 8th, and 16th weeks, assessments will be conducted for hip abductor and adductor eccentric and isometric muscle strength, flexibility of the hip adductors, level of delayed muscle soreness, single-leg jump test, and timed lateral hop tests. The outcome of our study will determine how much improvement is achieved in hip muscle strength and lower extremity physical fitness parameters during and after the application of the Copenhagen adduction exercise at different loading intensities.

NCT ID: NCT05853640 Recruiting - Hip Pain Chronic Clinical Trials

Education and Exercise for Patients With Longstanding Hip and Groin Pain

HIPSTER
Start date: July 24, 2023
Phase: N/A
Study type: Interventional

Longstanding hip and groin pain (LHGP) is a common and debilitating problem in young to middle aged individuals. These patients often get referred to orthopedic departments. Consensus statements on the management of these patients commonly recommend a physical therapist-led intervention as the first line intervention. However, the optimal content and delivery of this intervention is currently unknown. In this study we will compare the effectiveness of usual care (unstructured physical therapist-led intervention) to a semi-structured, progressive individualized physical therapist-led intervention on hip-related quality of life in people with longstanding hip and groin pain referred to an orthopedic department.

NCT ID: NCT05554562 Recruiting - Groin Injury Clinical Trials

Adductor Strength in Athletes Suffering a Groin Injury

Start date: September 26, 2022
Phase:
Study type: Observational

assess the difference in adductor peak strength evaluated with different instruments. Hand held dynamometer vs force frame

NCT ID: NCT03496649 Recruiting - Tendinopathy Clinical Trials

Pubalgia and Adductor Tendinopathies Refractory to Medical Treatment

PETRA
Start date: May 2, 2019
Phase: Phase 2
Study type: Interventional

Pubalgia is a pain syndrome located in the groin area. This syndrome is mainly described in young male athletes and typically affect the superficial muscles defining the boundaries of the femoral triangle, i.e. gracilis, pectineus, adductor brevis and especially adductor longus, and less commonly the deep muscles. Clinically, the pain is located in the inner aspect of the thigh, where the tendons attach onto the pubic symphysis. It is usually unilateral, and sometimes associated with neuropathic pain suggestive of obturator nerve irritation. There is no official recommendation or expert consensus on the management of pubalgia. However, a few protocols recommend a period of rest with Non-Inflammatory Anti-Steroidien Drugs (NSAIDs), icing and massages, as well as rehabilitation with passive stretching and muscle reinforcement. The use of botulinum toxin type A could be an option in cases of treatment failure. However, a feasibility study must be performed beforehand, and if results are positive, a controlled study on a larger cohort could be conducted. The major potential impact is a great effective pain relief for patients with neurological diseases.